decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 7 (July)
HGSA will now cover 18 shots of Macugen
Subscribe or sign in to view the full article.
Article Overview
This piece explains a Medicare carrier draft local coverage decision affecting Macugen coverage for macular degeneration in Pennsylvania. It is relevant to ophthalmology, medical billing, and Medicare reimbursement staff because it discusses the scope of coverage, the diagnosis basis, treatment duration considerations, and related reporting and billing items under the carrier policy. The article also places the policy in context by noting other contractor positions on the same treatment.
Why This Topic Matters
Coverage policy changes can affect whether a patient’s treatment is payable, how claims are documented, and when additional review may apply. For practices administering expensive ophthalmic therapy, understanding contractor-specific guidance helps reduce denials and support compliant billing.
What You Will Learn
- How a Medicare contractor draft coverage decision addresses an ophthalmic drug treatment
- What general documentation and billing issues the policy highlights
- How treatment duration and medical review considerations can affect coverage
- How local carrier policies can differ across Medicare contractors
Who Should Read This
- Medical coders
- Billing specialists
- Ophthalmology practices
- Practice managers
- Compliance staff
- Medicare reimbursement staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com